RING CHRISTINE (General Counsel) sold 6.9% of their position (3.76K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $67.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/18/2025ACC: 0001817199-25-000010
Officer· General Counsel
Since Jul 2020
-3.76K
Net shares
Net seller
$67.3K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
3.76K acquired · 7.52K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+3.76K
Price / share
$1.86
Trade value
$6.99K
% of position
7.4%
12/18/2025
50.90K→54.66K
Common Stock
Direct
Shares
−3.56K
Price / share
$17.87
Trade value
$63.60K
% of position
6.5%
12/18/2025
54.66K→51.10K
Common Stock
Direct
Shares
−200.00
Price / share
$18.55
Trade value
$3.71K
% of position
0.4%
12/18/2025
51.10K→50.90K
Total
Net shares
+0.00
Net value
-$60.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/18/2025 | M · Option Exercise | +3.76K | $1.86 | $6.99K | 7.4% | 50.90K | 54.66K |
| Common Stock Direct | 12/18/2025 | S · Sale | −3.56K | $17.87 | $63.60K | 6.5% | 54.66K | 51.10K |
| Common Stock Direct | 12/18/2025 | S · Sale | −200.00 | $18.55 | $3.71K | 0.4% | 51.10K | 50.90K |
| Total | +0.00 | -$60.32K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
3.76K shares
Shares
−3.76K
Strike price
1.86
Held after
12.40K
Exercisable
—
12/18/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock3.76K shares | 12/18/2025 | M · Option Exercise | −3.76K | 1.86 | — | 12.40K |